Jean-François Bonfanti
46Patents
6h-index
39Co-inventors
65Inventor score
Filing activity: Dec 20, 2004 → Oct 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9556176B2 | Purine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 29 | Active |
| US9416114B2 | 1,2,4-triazine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 26 | Active |
| US9944598B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US10029984B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US10206902B2 | Mono- or di-substituted indoles as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 14 | Active |
| US8497270B2 | Macrocyclic integrase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US7449463B2 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 4 | Expired |
| US8034835B2 | 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs | Chemistry; Metallurgy | 3 | Active |
| US10689340B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US10696632B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10919854B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10266543B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 2 | Active |
| US10280167B2 | Purine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US10280180B2 | Macrocyclic purines for the treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US11827602B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11180450B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9725432B2 | Pyrimidine derivatives for the treatment of bacterial diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US11179368B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8044073B2 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
| US7994173B2 | 2-piperazin-1-yl-3H-imidazo[4,5-b]pyridine derivatives | Human Necessities | 0 | Active |
| US11312727B1 | Macrocyclic flu endonuclease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11795149B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8178694B2 | Heterocyclylaminoalkyl substituted benzimidazoles | Chemistry; Metallurgy | 0 | Active |
| US11702426B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
| US7956196B2 | 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.